Now showing items 1-3 of 3

    • Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial 

      Kato, Eri Toda; Giugliano, Robert P.; Ruff, Christian T.; Koretsune, Yukihiro; Yamashita, Takeshi; Kiss, Robert Gabor; Nordio, Francesco; Murphy, Sabina A.; Kimura, Tetsuya; Jin, James; Lanz, Hans; Mercuri, Michele; Braunwald, Eugene; Antman, Elliott M. (John Wiley and Sons Inc., 2016)
      Background: Elderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical ...
    • Incidence of Sudden Cardiac Death in a Young Active Population 

      Farioli, Andrea; Christophi, Costas A; Quarta, Candida Cristina; Kales, Stefanos N (John Wiley & Sons, Ltd, 2015)
      Background: Little is known about the burden of sudden cardiac death (SCD) among active, presumably healthy persons. We investigated the incidence of SCD among US male career firefighters. Methods and Results: All on-duty ...
    • Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study 

      Kramer, Daniel B; Mitchell, Susan L; Monteiro, Joao; Jones, Paul W; Normand, Sharon-Lise; Hayes, David L; Reynolds, Matthew R (John Wiley & Sons, Ltd, 2015)
      Background: Physical activity data are collected automatically by implantable cardioverter-defibrillators (ICDs). Though these data potentially provide a quantifiable and easily accessible measure of functional status, its ...